Phase II trial of edatrexate plus carboplatin in metastatic non-small- cell lung cancer: A Southwest Oncology Group study

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 1, 1997, Pages 75-78

  Gandara, D R ^a,b   Edelman, Martin J ^a,b   Crowley, John J ^c   Lau, Derick H M ^a,b   Livingston, Robert B ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^c SW Oncology Group Statistical Center ^*  (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Carboplatin; Edatrexate; Non small cell lung cancer

Indexed keywords

CARBOPLATIN; EDATREXATE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CRYOTHERAPY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PRIORITY JOURNAL; SEPSIS;

ADULT; AGED; AMINOPTERIN; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOUTH MUCOSA; NEUTROPENIA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0031408689     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050710     Document Type: Article

References (21)

1. Bonomi PD, Finkelstein DM, Ruckdeschel JC, et al (1989) Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol 7: 1602-1613
2. Cartei G, Cartei F, Cantone A, et al (1993) Cisplatin-cyclo-phosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer. J Natl Cancer Inst 85: 794-800
3. Dillman RO, Seagren SL, Propert KJ, et al (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323: 940-945
4. Ellis PA, Smith IE, Hardy JR, et al (1995) Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small cell lung cancer. Br J Cancer 71: 366-370
5. Gandara DR, Perez EA, Edelman MJ, et al (1995) Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy. Proc Am Soc Clin Oncol 14: 468 (#1513)
6. Gatzemeier U, Heckmayr M, Hossfield DK et al (1990) Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer. Cancer Chemother Pharmacol 26: 369-372
7. Grant SC, Kris MG, Young CW, Sirotnak FM (1993) Edatrexate: an antifolate with antitumor activity. A review. Cancer Invest 11(1): 36-45
8. Green MR, Kreisman H, Luikart S, et al (1990) Carboplatin in non-small cell lung cancer: the Cancer and Leukemia Group B experience. In: Bunn PA, Canetta R, Ozols RF, Rozencweig M (eds) Carboplatin (JM-8): current perspectives and future directions. W.B. Saunders Company, Philadelphia, pp 301-306
9. Japan Cooperative Oncology Group on Lung Cancer (1990) Phase II study of carboplatin in patients with nonresected lung cancer. Cancer Chemother Pharmacol 26: 101-104
10. Klastersky J, Sculier JP, Lacroiz H, et al (1990) A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol 8: 1556-1562
11. Lee JS, Libshitz HI, Murphy WK, et al (1990) Phase II study of 10-ethyl-10-deaza-aminopterin (10-EDAM, CGP 30 694) for stage IIIB or IV non-small cell lung cancer. Invest New Drugs 8: 299-304
12. Lee JS, Libshitz HI, Fossella FV (1992) Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small cell lung cancer. J Natl Cancer Inst 84: 1039-1040
13. Marino P, Pampallona S, Preatoni A, et al (1994) Chemotherapy vs supportive care in advanced non-small cell lung cancer. Results of a meta-analysis of the literature. Chest 106: 861-865
14. Olver IN, Donehower RC, Van Echo DA, et al (1986) Phase II trial of carboplatin in non-small cell lung cancer. Cancer Treat Rep 70: 421
15. Perez EA, Hack FM, Webber LM, Chou TC (1993) Schedule-dependent synergism of edatrexate and cisplatin combination in the A549 lung-cancer cell line as assessed by median-effect analysis. Cancer Chemother Pharmacol 33: 245-250
16. Perez EA, Hack FM, Fletcher TS, Chou T-C (1994) Modulation of intrinsic in vitro resistance to carboplatin by edatrexate. Oncol Res 6: 151-156
17. Perez EA, Whittal D, Hesketh PJ (1994) Phase I trial of biweekly edatrexate in breast cancer (abstract). Proc Am Soc Clin Oncol 13: 59
18. Rapp E, Pater JL, Willan A, et al (1988) Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer - report of a Canadian multicenter randomized trial. J Clin Oncol 6: 633-641
19. Shum KY, Kris MG, Gralla RJ, et al (1988) Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small cell lung cancer. J Clin Oncol 6: 446-450
20. Souhami RL, Rudd RM, Spiro SG, et al (1992) Phase II study of edatrexate in stage III and IV non-small cell lung cancer. Cancer Chemother Pharmacol 30: 465-468
21. Souquet P-J, Chauvin F, Boissel JP, Bernard JP (1995) Meta-analysis of randomized trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer. Lung Cancer 12 [Suppl 1]: S147-S154